全文获取类型
收费全文 | 10900篇 |
免费 | 1036篇 |
国内免费 | 833篇 |
专业分类
耳鼻咽喉 | 121篇 |
儿科学 | 72篇 |
妇产科学 | 120篇 |
基础医学 | 1365篇 |
口腔科学 | 137篇 |
临床医学 | 1317篇 |
内科学 | 1729篇 |
皮肤病学 | 92篇 |
神经病学 | 658篇 |
特种医学 | 370篇 |
外国民族医学 | 6篇 |
外科学 | 1116篇 |
综合类 | 1855篇 |
预防医学 | 640篇 |
眼科学 | 293篇 |
药学 | 1160篇 |
10篇 | |
中国医学 | 615篇 |
肿瘤学 | 1093篇 |
出版年
2024年 | 20篇 |
2023年 | 162篇 |
2022年 | 254篇 |
2021年 | 580篇 |
2020年 | 453篇 |
2019年 | 363篇 |
2018年 | 392篇 |
2017年 | 317篇 |
2016年 | 362篇 |
2015年 | 526篇 |
2014年 | 620篇 |
2013年 | 516篇 |
2012年 | 783篇 |
2011年 | 912篇 |
2010年 | 509篇 |
2009年 | 392篇 |
2008年 | 636篇 |
2007年 | 521篇 |
2006年 | 513篇 |
2005年 | 597篇 |
2004年 | 388篇 |
2003年 | 416篇 |
2002年 | 340篇 |
2001年 | 276篇 |
2000年 | 277篇 |
1999年 | 266篇 |
1998年 | 196篇 |
1997年 | 169篇 |
1996年 | 148篇 |
1995年 | 127篇 |
1994年 | 103篇 |
1993年 | 64篇 |
1992年 | 80篇 |
1991年 | 93篇 |
1990年 | 86篇 |
1989年 | 68篇 |
1988年 | 60篇 |
1987年 | 61篇 |
1986年 | 41篇 |
1985年 | 38篇 |
1984年 | 14篇 |
1983年 | 8篇 |
1982年 | 9篇 |
1981年 | 4篇 |
1980年 | 1篇 |
1979年 | 5篇 |
1978年 | 1篇 |
1968年 | 1篇 |
1936年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 109 毫秒
1.
2.
Yulong Lian Jing Xiao Chen Zhang Suzhen Guan Fuye Li Hua Ge 《Archives of environmental & occupational health》2016,71(2):74-84
The present study compared the level of occupational strain and work ability among Han, Hui, Uygur, Hui, and Kazakh teachers, and explored ethnic differences based on the associations of psychosocial factors at work, occupational strain, and work ability. A cross-sectional survey was conducted among 2,941 teachers in primary and secondary schools in Xinjiang Province, China. Psychosocial factors, occupational strain, and work ability were measured using the Occupation Stress Inventory—Revised Edition (OSI-R) and Work Ability Index. Han and Hui teachers experienced reduced work ability compared with Uygur and Kazakh teachers, and this finding was caused, in part, by exposure to psychosocial factors at work. The vocational and psychological strains caused by these factors play an important role in reduced work ability among all ethnic teacher groups. The findings indicate the importance of taking action to reduce occupational strain for promoting teachers' work ability in multiethnic workplaces. 相似文献
3.
4.
5.
Platelet function has been described by many laboratory assays, and PL-11 is a new point-of-care platelet function analyzer based on platelet count drop method, which counts platelet before and after the addition of agonists in the citrated whole blood samples. The present study sought to compare PL-11 with other three major more established assays, light transmission aggregometry (LTA), VerifyNow? aspirin system and thromboelastography (TEG), for monitoring the short-term aspirin responses in healthy individuals. Ten healthy young men took 100?mg/d aspirin for 3-day treatment. Platelet function was measured via PL-11, LTA, VerifyNow and TEG, respectively. The blood samples were collected at baseline, 2 hour, 1 day during the aspirin treatment and 1 day, 5?±?1 days, 8?±?1 days after the aspirin withdrawal. Moreover, 90 additional healthy subjects were recruited to establish a reference range for PL-11. Platelet function of healthy subjects decreased significantly 2 hours after 100?mg/d aspirin intake and began to recover during 4–6 days after the aspirin withdrawal. Correlations between methods were PL-11 vs. LTA (r?=?0.614, p?<?0.01); PL-11 vs. VerifyNow (r?=?0.829, p?<?0.01); PL-11 vs. TEG (r?=?0.697, p?<?0.001). There was no significant bias between PL-11 and LTA at baseline (bias?=?1.94%, p?=?0.804) using Bland-Altman analysis, while the data of PL-11 were significantly higher than LTA (bias?=?24.02%, p?<?0.001) during the aspirin therapy. The reference range for PL-11 in healthy young individuals was from 66.8 to 90.5% (95%CI). When aspirin low-responsiveness was defined as LTA?>?20%, the cut-off values for each method were, respectively: PL-11?>?50%, VerifyNow?>?533 ARU, TEG?>?60.2%. The results of different platelet function assays were uninterchangeable for monitoring aspirin response and correlations among them were also varied. Correlations among PL-11 and other three major assays suggested the ability of PL-11 to assess the treatment effects of aspirin. But a large cohort study is needed to confirm the cut-off value of aspirin response detected by PL-11. 相似文献
6.
7.
8.
以培养创新型人才为目标,大连医科大学制定实施了“5+3”创新人才培养改革方案,以导师制培养为载体,在医学本科教育全过程中,制定分阶段创新能力培养体系,涵盖课程、讲座、实验设计、论文等基本科研能力训练,强化本科生科研能力培养。通过对首届“5+3”学生阶段性培养成果的统计学分析发现,“5+3”学生发表中文期刊、SCI,主持国家级创新项目、省级创新项目的比例均显著高于普通5年制学生,差异具有统计学意义(P<0.05)。虽然实施过程中存在一些问题和不足,但以导师制为核心的科研基础训练对提高学生科研思维和创新能力效果显著,对培养医学创新型人才具有可实施性。 相似文献
9.
Miao-Zhen Qiu Cai-Yun He Shi-Xun Lu Wen-Long Guan Fang Wang Xiao-Jian Wang Ying Jin Feng-Hua Wang Yu-Hong Li Jian-Yong Shao Zhi-Wei Zhou Jing-Ping Yun Rui-Hua Xu 《International journal of cancer. Journal international du cancer》2020,146(1):272-280
Epstein–Barr virus (EBV)-associated gastric carcinomas (EBVaGCs) may account for 8–9% of all gastric cancer (GC) patients. All previous reports on EBVaGC were retrospective. Prospective study is warranted to evaluate the exact role of EBV status in predicting the prognosis of GC. It is of special interest to figure out whether dynamic detection of plasma EBV-DNA load could be a feasible biomarker for the monitor of EBVaGC. From October 2014 to September 2017, we consecutively collected GC patients (n = 2,760) from Sun Yat-sen University Cancer Center for EBER examination. We detected EBV-DNA load in plasma and tissue samples of EBVaGC patients at baseline. Subsequently, plasma EBV-DNA load was dynamically monitored in EBVaGC patients. The overall prevalence of EBVaGC is 5.1% (140/2,760). The incidence rate of EBVaGC decreased with advanced AJCC 7th TNM stage (p < 0.001), with the corresponding percentages of 9.3, 9.9, 6.7 and 1.4% for Stage I, II, III and IV patients. EBVaGC patients were predominately young males with better histologic differentiation and earlier TNM stage than EBV-negative GC (EBVnGC) patients. EBVaGC patients were confirmed to had a favorable 3-year survival rate (EBVaGC vs. EBVnGC: 76.8% vs. 58.2%, p = 0.0001). Though only 52.1% (73/140) EBVaGC patients gained detectable EBV-DNA and 43.6% (61/140) reached a positive cutoff of 100 copies/ml, we found the plasma EBV-DNA load in EBVaGC decreased when patients got response, while it increased when disease progressed. Our results suggested that plasma EBV-DNA is a good marker in predicting recurrence and chemotherapy response for EBVaGC patients. 相似文献
10.
Jinlan He Jianxiong He Li Min Yan He Hui Guan Jingjing Wang Xingchen Peng 《International journal of cancer. Journal international du cancer》2020,146(4):1052-1063
Sorafenib provides survival benefits in patients with advanced renal cell carcinoma (RCC), but its use is hampered by acquired drug resistance. It is important to fully clarify the molecular mechanisms of sorafenib resistance, which can help to avoid, delay or reverse drug resistance. Extracellular vesicles (EVs) can mediate intercellular communication by delivering effector molecules between cells. Here, we studied whether EVs are involved in sorafenib resistance of RCC and its possible molecular mechanisms. Using differential centrifugation, EVs were isolated from established sorafenib-resistant RCC cells (786-0 and ACHN), and EVs derived from sorafenib-resistant cells were uptaken by sensitive parental RCC cells and thus promoted drug resistance. Elevated exogenous miR-31-5p within EVs effectively downregulated MutL homolog 1 (MLH1) expression and thus promoted sorafenib resistance in vitro. Mice experiments also confirmed that miR-31-5p could mediate drug sensitivity in vivo. In addition, low expression of MLH1 was observed in sorafenib-resistant RCC cells and upregulation of MLH1 expression restored the sensitivity of resistant cell lines to sorafenib. Finally, miR-31-5p level in circulating EVs of RCC patients with progressive disease (PD) during sorafenib therapy was higher when compared to that in the pretherapy status. In conclusion, EVs shuttled miR-31-5p can transfer resistance information from sorafenib-resistant cells to sensitive cells by directly targeting MLH1, and thus magnify the drug resistance information to the whole tumor. Furthermore, miR-31-5p and MLH1 could be promising predictive biomarkers and therapeutic targets to prevent sorafenib resistance. 相似文献